Search

Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 610.90 -8.50  | -1.37% -29.89% 14.16 17,243.03
NSE Price: Aug 18, 2017 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Aug 18, 2017 610.90 -8.50 -1.37% 619.00 619.40 680,436 605.00 - 619.00
BSE Aug 18, 2017 611.00 -9.05 -1.46% 619.30 620.05 48,171 605.55 - 619.30
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 1,215,077 P/B: 3.57 NSE Code: GLENMARK
52-Week Range: R 592.10 - 994.00 Dividend Yield: 0.33% BSE Code: 532296
TTM EPS: R 43.15 Book Value: R 171.00 Face Value: R 1
Price Graph
  • Biocon (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. -31.24 -11.65 -9.46 -29.89 -5.76 8.02 7.08
S&P BSE Mid Cap 26.41 0.67 3.10 17.28 18.35 19.80 9.27
S&P BSE Healthcare -12.15 -12.34 -13.19 -20.15 0.66 12.00 13.99
Company's return has been calculated on basis of NSE's price.
As on Aug 18, 2017
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 15.55 15.82 21.22
Net Profit 243.67 4.64 9.47
EPS 230.41 3.69 8.76
Book Value 64.77 2.02 7.52
Average
Operating Margin 18.83 18.55 18.90
Net Margin 9.30 7.20 9.14
Return on Networth 29.75 19.18 20.56
Return on Investment 19.04 15.49 15.72
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -3.83 19.99 2.44
Operating Profit 50.99 30.27 88.08
Net Profit 81.42 47.01 124.05
EPS 81.42 47.01 124.04
TTM
Revenue 4.29 20.29 25.35
Operating Profit 6.64 42.93 51.79
Net Profit 9.59 54.59 63.71
EPS 9.59 54.56 63.66
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 17,243.03 9,579.30 1,217.83 12.74 29.75 3.57 14.16
Biocon 19,719.00 3,848.20 588.40 14.60 15.15 4.01 37.43
Torrent Pharmaceuticals 21,454.06 5,680.00 830.00 13.87 23.80 4.73 25.85
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Feb 08, 2017 Oppenheimer Fund Inc(FII)  Buy Market 74,647 957.70 714.89
Nov 09, 2016 Robin Pinto  Buy Market 500 899.50 4.50
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 12,200 707.70 86.34
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 20,000 707.70 141.54
Sep 11, 2014 Blanche Elizabeth Saldanha  Buy Market 17,980 765.30 137.60
Fund Houses invested in the stock
Fund Jun-17 Mar-17 Dec-16 Sep-16 Jun-16
Aditya Birla Sun Life Mutual Fund 0.530 0.989 0.977 - -
Reliance Mutual Fund 0.496 0.343 0.314 0.043 0.007
Kotak Mahindra Mutual Fund 0.464 0.156 0.117 0.063 0.098
Tata Mutual Fund 0.260 0.901 0.921 0.861 0.697
HDFC Mutual Fund 0.170 0.146 0.113 0.139 0.117
Franklin Templeton Mutual Fund 0.107 - - - -
SBI Mutual Fund 0.090 0.277 0.259 0.192 0.229
HSBC Mutual Fund 0.080 0.080 0.097 0.087 0.087
IDFC Mutual Fund 0.079 0.050 0.091 0.031 0.049
BNP Paribas Mutual Fund 0.071 0.076 0.072 - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: [email protected]

Website: www.glenmarkpharma.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
3.88
Piotroski F-Score
7
Modified C-Score
2
5-Years Price to Earnings
14.45
5-Years Price to Book
3.65
Earnings Yield
EBIT / Enterprise value
8.95%
PEG
Price / Earnings to growth ratio
0.49
Related Stocks
  Current Price   Chng %
Ajanta Pharma R1,205.60 -0.81%
Alembic Pharmaceuticals R517.95 +0.47%
Alkem Laboratories R1,799.85 -1.03%
Biocon R328.95 +0.17%
Divi's Laboratories R635.20 -1.63%
Glaxosmithkline Pharma R2,395.80 +0.14%
Jubilant Life Sciences R703.40 -2.59%
Natco Pharma R755.85 -2.16%
Sanofi India R4,028.25 -1.69%
Torrent Pharmaceuticals R1,270.65 -3.13%
As on Aug 18, 2017